Catalyst Wire Dossier Catalyst Wire Dossier

Iadademstat

iadademstat · Oryzon Genomics
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Iadademstat, covering 2024-07-29 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer [Phase 1, Phase 2]

See pricing